157 related articles for article (PubMed ID: 21804164)
1. Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation.
Lorillon G; Robin M; Meignin V; Ribaud P; Lescoeur B; Gossot D; Socié G; Tazi A; Bergeron A
Eur Respir J; 2011 Aug; 38(2):470-2. PubMed ID: 21804164
[No Abstract] [Full Text] [Related]
2. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience.
Vogl UM; Nagayama K; Bojic M; Hoda MA; Klepetko W; Jaksch P; Dekan S; Siersch V; Mitterbauer M; Schellongowski P; Greinix HT; Petkov V; Schulenburg A; Kalhs P; Rabitsch W
Transplantation; 2013 Feb; 95(4):623-8. PubMed ID: 23274967
[TBL] [Abstract][Full Text] [Related]
3. Effect of Rituximab on Pulmonary Function in Bronchiolitis Obliterans Syndrome due to Graft-Versus-Host-Disease.
Brownback KR; Thomas LA; McGuirk JP; Ganguly S; Streiler C; Abhyankar S
Lung; 2017 Dec; 195(6):781-788. PubMed ID: 28894914
[TBL] [Abstract][Full Text] [Related]
4. Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation.
Hostettler KE; Halter JP; Gerull S; Lardinois D; Savic S; Roth M; Tamm M
Eur Respir J; 2014 Jan; 43(1):221-32. PubMed ID: 23645405
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness and safety of rituximab in pemphigus vulgaris].
Alonso Sánchez A; García Rodríguez S; López Avila A; Rabell Iñigo S
Farm Hosp; 2010; 34(2):98-9. PubMed ID: 20304370
[No Abstract] [Full Text] [Related]
6. Refractory bullous pemphigoid with fatal outcome in a young patient.
Cruz MJ; Santos P; Morais P; Barreto F; Azevedo F
Int J Dermatol; 2013 May; 52(5):601-2. PubMed ID: 23590375
[No Abstract] [Full Text] [Related]
7. Intraoral psoralen ultraviolet A irradiation (PUVA) treatment of refractory oral chronic graft-versus-host disease following allogeneic stem cell transplantation.
Menillo SA; Goldberg SL; McKiernan P; Pecora AL
Bone Marrow Transplant; 2001 Oct; 28(8):807-8. PubMed ID: 11781637
[No Abstract] [Full Text] [Related]
8. Preliminary results of rescue therapy with tacrolimus and mycophenolate mofetil in lung transplanted patients with bronchiolitis obliterans.
Roman A; Bravo C; Monforte V; Reyes L; Canela M; Morell F
Transplant Proc; 2002 Feb; 34(1):146-7. PubMed ID: 11959227
[No Abstract] [Full Text] [Related]
9. Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy.
Yang T; Nast CC; Vo A; Jordan SC
Nephrol Dial Transplant; 2008 Jan; 23(1):377-80. PubMed ID: 17981884
[No Abstract] [Full Text] [Related]
10. Where does rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease?
Nigam R; Levitt J
J Drugs Dermatol; 2012 May; 11(5):622-5. PubMed ID: 22527431
[TBL] [Abstract][Full Text] [Related]
11. Bronchiolitis obliterans syndrome after lung transplantation: medical treatment.
Verleden GM
Monaldi Arch Chest Dis; 2000 Apr; 55(2):140-5. PubMed ID: 10949876
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin inhibitor-free graft-versus-host disease prophylaxis with sirolimus and mycophenolate mofetil in a second allogeneic stem cell transplantation for engraftment failure and rituximab-refractory Epstein-Barr virus-induced posttransplant lymphoproliferative disease.
Ceppi F; Duval M; Teira P; Therrien R; Ovetchkine P; Mallette B; Bittencourt H
J Pediatr Hematol Oncol; 2014 Jul; 36(5):e319-21. PubMed ID: 24977404
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus for treatment of bronchiolitis obliterans syndrome after unilateral and bilateral lung transplantation.
Fieguth HG; Krueger S; Wiedenmann DE; Otterbach I; Wagner TO
Transplant Proc; 2002 Aug; 34(5):1884. PubMed ID: 12176613
[No Abstract] [Full Text] [Related]
14. Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options.
Uhlving HH; Buchvald F; Heilmann CJ; Nielsen KG; Gormsen M; Müller KG
Bone Marrow Transplant; 2012 Aug; 47(8):1020-9. PubMed ID: 21874057
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of severe myasthenia gravis developed after allogeneic hematopoietic stem cell transplantation with plasma exchange and rituximab.
Unal S; Sag E; Kuskonmaz B; Kesici S; Bayrakci B; Ayvaz DC; Tezcan I; Yalnızoglu D; Uckan D
Pediatr Blood Cancer; 2014 May; 61(5):928-30. PubMed ID: 24307660
[TBL] [Abstract][Full Text] [Related]
16. An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients.
Bhatia M; Militano O; Jin Z; Figurski M; Shaw L; Moore V; Morris E; Tallamy B; van deVen C; Ayello J; Baxter-Lowe L; Satwani P; George D; Bradley MB; Garvin J; Cairo MS
Biol Blood Marrow Transplant; 2010 Mar; 16(3):333-43. PubMed ID: 19835971
[TBL] [Abstract][Full Text] [Related]
17. Rituximab therapy for acute humoral rejection after kidney transplantation.
Faguer S; Kamar N; Guilbeaud-Frugier C; Fort M; Modesto A; Mari A; Ribes D; Cointault O; Lavayssière L; Guitard J; Durand D; Rostaing L
Transplantation; 2007 May; 83(9):1277-80. PubMed ID: 17496547
[TBL] [Abstract][Full Text] [Related]
18. [Vasculitis].
Fleck M; Hellmich B
Dtsch Med Wochenschr; 2011 Jun; 136(22):1194-6. PubMed ID: 21611928
[No Abstract] [Full Text] [Related]
19. Lung transplantation under a tacrolimus/mycophenolate mofetil-based immunosuppressive regimen results in low titers of HLA and MICA IgG antibodies which are not related to development of BOS.
Paantjens AW; van de Graaf EA; van Ginkel WG; van den Bosch JM; Otten HG
J Heart Lung Transplant; 2010 May; 29(5):596-8. PubMed ID: 20207170
[No Abstract] [Full Text] [Related]
20. Tamibarotene for the Treatment of Bronchiolitis Obliterans Associated With Chronic Graft-vs-Host Disease.
Watanabe S; Ishiyama K; Saeki K; Ohkura N; Kasahara K; Nakao S
Chest; 2019 Jan; 155(1):e1-e4. PubMed ID: 30616741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
